ArticleJournal for immunotherapy of cancer2021

Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.

Anna Dalla Pietà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.